Access cutting-edge type 2 diabetes treatment through this clinical trial at a research site in San Antonio. Study-provided care at no cost to qualified participants.
Access type 2 diabetes specialists in San Antonio at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 2 diabetes treatment provided free
The primary purpose of this study is to evaluate the efficacy, durability, and mechanism of HbA1c reduction produced by the combination of pioglitazone plus tirzepatide compared to metformin plus sitagliptin in patients with recently diagnosed type 2 diabetes mellitus.
Sponsor: The University of Texas Health Science Center at San Antonio
Check if you qualify for this type 2 diabetes clinical trial in San Antonio, TX
If you're searching for type 2 diabetes treatment options in San Antonio, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Antonio research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.